Literature DB >> 2557117

Neuropeptides as growth regulators.

P J Woll, E Rozengurt.   

Abstract

The classical role of neuropeptides as fast-acting neurohumoral signallers has recently been challenged by the discovery that many neuropeptides are also growth factors stimulating slow-acting mitogenesis. Their mechanisms of action have been studied in cell culture, and their cell-surface receptors have been characterized pharmacologically using agonists and antagonists. We describe the mitogenic effects of bombesin, vasopressin, bradykinin and vasoactive intestinal peptide in murine fibroblasts. We suggest that the receptors for bombesin, vasopressin and bradykinin have more than one binding site, permitting modulation of transmitted signals. As these neuropeptide receptors share the ability to mobilize intracellular Ca2+, their common domain may be essential to G-protein coupling.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557117     DOI: 10.1093/oxfordjournals.bmb.a072337

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  5 in total

Review 1.  The significance of substance P in physiological and malignant haematopoiesis.

Authors:  Michal Nowicki; Danuta Ostalska-Nowicka; Beata Kondraciuk; Bogdan Miskowiak
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

2.  An immunohistochemical study of the catecholamine synthesizing enzymes and neuropeptides in the female guinea-pig uterus and vagina.

Authors:  B S Mitchell; E Ahmed
Journal:  Histochem J       Date:  1992-06

Review 3.  Neurohypophyseal peptides as regulators of growth and development. A review.

Authors:  D A Carter; C K Fai; D Murphy
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

Review 4.  Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.

Authors:  Mahjabin Khan; Tao Huang; Cheng-Yuan Lin; Jiang Wu; Bao-Min Fan; Zhao-Xiang Bian
Journal:  Oncotarget       Date:  2017-06-07

5.  Growth Impairment of Small-Cell Cancer by Targeting Pro-Vasopressin with MAG-1 Antibody.

Authors:  William G North; Bernard Cole; Bonnie Akerman; Roy H L Pang
Journal:  Front Oncol       Date:  2014-02-11       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.